Market closed

Lexicon Pharmaceuticals/$LXRX

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About Lexicon Pharmaceuticals

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.

Ticker

$LXRX
Trading on

Industry

Biotechnology

Employees

285

LXRX Metrics

BasicAdvanced
$459M
Market cap
-
P/E ratio
-$0.78
EPS
1.36
Beta
-
Dividend rate
$459M
1.36
$3.73
$0.94
3.7M
11.51
11.213
41.461
41.461
-11.96%
-35.69%
-94.81%
91.288
1.64
2.02
-1.694
794.59%
12.57%
-19.93%
38.39%

What the Analysts think about LXRX

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Lexicon Pharmaceuticals stock.

LXRX Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

LXRX Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $LXRX

$

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Lexicon Pharmaceuticals stock?

Lexicon Pharmaceuticals (LXRX) has a market cap of $459M as of November 13, 2024.

What is the P/E ratio for Lexicon Pharmaceuticals stock?

The price to earnings (P/E) ratio for Lexicon Pharmaceuticals (LXRX) stock is 0 as of November 13, 2024.

Does Lexicon Pharmaceuticals stock pay dividends?

No, Lexicon Pharmaceuticals (LXRX) stock does not pay dividends to its shareholders as of November 13, 2024.

When is the next Lexicon Pharmaceuticals dividend payment date?

Lexicon Pharmaceuticals (LXRX) stock does not pay dividends to its shareholders.

What is the beta indicator for Lexicon Pharmaceuticals?

Lexicon Pharmaceuticals (LXRX) has a beta rating of 1.36. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.